The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

Weight loss while taking Zepbound varies depending on individual factors, including response to the drug, initial body weight, lifestyle habits, and dosage. Clinical trials have shown that people ...

Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, according to new research. Building on previous studies that show weight ...

Drinking Water to Lose Weight: What’s the Idea? You've probably heard many of the ways water is good for you – it helps move waste out of your body, helps your cells work the way they should, ...

Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 ...

Novo Nordisk A/S (NYSE:NVO) is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company recently highlighted early data that shows safety and efficacy figures that are ...

At least 82 people in Britain are known to have died after taking one of the new wave of weight-loss drugs, according to The Medicines and Healthcare products Regulatory Agency (MHRA) data up to ...

#9 UFC Bantamweight Rob Font boxed up the undefeated Jean Matsumoto at UFC Seattle. A former Top-5 contender in the UFC's bantamweight division, Font was scheduled to defend his #9 ranking against ...

Jelly Roll continues to impress the world with his weight loss journey. The famed rapper and country singer hasn't been shy about sharing details of his efforts to get healthier. Now, the 40-year-old ...

Four in five adults who are trying to lose weight are eager to reach their goal as soon as possible (81%), according to new research. A survey of 2,000 U.S. adults who are trying to lose weight found ...

Thursday on the RealClearPolitics radio show, RCP co-founder Tom Bevan, Washington bureau chief Carl Cannon, and podcast host Andrew Walworth review how the site's poll averages performed during the ...